Logo image of TRBR.CA

TRUBAR INC (TRBR.CA) Stock Fundamental Analysis

TSX-V:TRBR - CA82888R1055 - Common Stock

0.67 CAD
-0.01 (-1.47%)
Last: 9/2/2025, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, TRBR scores 2 out of 10 in our fundamental rating. TRBR was compared to 35 industry peers in the Pharmaceuticals industry. TRBR has a bad profitability rating. Also its financial health evaluation is rather negative. TRBR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

TRBR had negative earnings in the past year.
In the past year TRBR had a positive cash flow from operations.
TRBR had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: TRBR reported negative operating cash flow in multiple years.
TRBR.CA Yearly Net Income VS EBIT VS OCF VS FCFTRBR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

The Return On Assets of TRBR (-1.47%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -22.83%, TRBR is in line with its industry, outperforming 42.86% of the companies in the same industry.
Industry RankSector Rank
ROA -1.47%
ROE -22.83%
ROIC N/A
ROA(3y)-53.1%
ROA(5y)-47.26%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TRBR.CA Yearly ROA, ROE, ROICTRBR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

TRBR has a Gross Margin (29.78%) which is comparable to the rest of the industry.
TRBR's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for TRBR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.17%
GM growth 5YN/A
TRBR.CA Yearly Profit, Operating, Gross MarginsTRBR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

2

2. Health

2.1 Basic Checks

TRBR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TRBR has been increased compared to 1 year ago.
Compared to 5 years ago, TRBR has more shares outstanding
TRBR has a better debt/assets ratio than last year.
TRBR.CA Yearly Shares OutstandingTRBR.CA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
TRBR.CA Yearly Total Debt VS Total AssetsTRBR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -0.82, we must say that TRBR is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of TRBR (-0.82) is comparable to the rest of the industry.
TRBR has a debt to FCF ratio of 6.61. This is a slightly negative value and a sign of low solvency as TRBR would need 6.61 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.61, TRBR is in the better half of the industry, outperforming 74.29% of the companies in the same industry.
TRBR has a Debt/Equity ratio of 2.69. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 2.69, TRBR is doing worse than 85.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.69
Debt/FCF 6.61
Altman-Z -0.82
ROIC/WACCN/A
WACC9.1%
TRBR.CA Yearly LT Debt VS Equity VS FCFTRBR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M -10M

2.3 Liquidity

A Current Ratio of 0.90 indicates that TRBR may have some problems paying its short term obligations.
TRBR has a worse Current ratio (0.90) than 82.86% of its industry peers.
A Quick Ratio of 0.74 indicates that TRBR may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.74, TRBR is doing worse than 74.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.9
Quick Ratio 0.74
TRBR.CA Yearly Current Assets VS Current LiabilitesTRBR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

6

3. Growth

3.1 Past

TRBR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.61%, which is quite impressive.
Looking at the last year, TRBR shows a very negative growth in Revenue. The Revenue has decreased by -42.52% in the last year.
TRBR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 42.58% yearly.
EPS 1Y (TTM)98.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.93%
Revenue 1Y (TTM)-42.52%
Revenue growth 3Y42.58%
Revenue growth 5YN/A
Sales Q2Q%3.75%

3.2 Future

Based on estimates for the next years, TRBR will show a very strong growth in Earnings Per Share. The EPS will grow by 29.10% on average per year.
The Revenue is expected to grow by 35.80% on average over the next years. This is a very strong growth
EPS Next Y0%
EPS Next 2Y29.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year41.19%
Revenue Next 2Y35.8%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
TRBR.CA Yearly Revenue VS EstimatesTRBR.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
TRBR.CA Yearly EPS VS EstimatesTRBR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 -0.05 -0.1 -0.15

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

TRBR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year TRBR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TRBR.CA Price Earnings VS Forward Price EarningsTRBR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, TRBR is valued a bit cheaper than 62.86% of the companies in the same industry.
Industry RankSector Rank
P/FCF 46.07
EV/EBITDA N/A
TRBR.CA Per share dataTRBR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4

4.3 Compensation for Growth

A more expensive valuation may be justified as TRBR's earnings are expected to grow with 29.10% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.1%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

TRBR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TRUBAR INC

TSX-V:TRBR (9/2/2025, 7:00:00 PM)

0.67

-0.01 (-1.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)08-25 2025-08-25/amc
Earnings (Next)11-17 2025-11-17
Inst Owners0.23%
Inst Owner ChangeN/A
Ins Owners22.39%
Ins Owner ChangeN/A
Market Cap72.22M
Analysts84
Price Target2.3 (243.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-200%
EPS NY rev (3m)-200%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.14
P/FCF 46.07
P/OCF 45.27
P/B 31.7
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)0.01
FCFY2.17%
OCF(TTM)0.01
OCFY2.21%
SpS0.59
BVpS0.02
TBVpS-0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.47%
ROE -22.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.78%
FCFM 2.48%
ROA(3y)-53.1%
ROA(5y)-47.26%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.17%
GM growth 5YN/A
F-Score5
Asset Turnover1.79
Health
Industry RankSector Rank
Debt/Equity 2.69
Debt/FCF 6.61
Debt/EBITDA N/A
Cap/Depr 1.3%
Cap/Sales 0.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.9
Quick Ratio 0.74
Altman-Z -0.82
F-Score5
WACC9.1%
ROIC/WACCN/A
Cap/Depr(3y)2.76%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.18%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.93%
EPS Next Y0%
EPS Next 2Y29.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-42.52%
Revenue growth 3Y42.58%
Revenue growth 5YN/A
Sales Q2Q%3.75%
Revenue Next Year41.19%
Revenue Next 2Y35.8%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y73.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year274.23%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y133.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y134.46%
OCF growth 3YN/A
OCF growth 5YN/A